Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
UCSF pediatrician and epidemiologist, Elena Fuentes-Afflick, MD, MPH, has been elected to the American Academy of Arts and Sciences, which honors exceptional scholars, leaders, artists and innovators. Fuentes-Afflick’s research has focused on the issues of acculturation, immigrant health and health disparities.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
The Science Policy Group at UCSF has initiated a project to provide alcohol-based hand sanitizer to incarcerated populations, as well as people living in public or transitional housing or experiencing homelessness, with plans to distribute 15,000 bottles.
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.